Literature DB >> 15191557

Penetration profile of microspheres in follicular targeting of terminal hair follicles.

R Toll1, U Jacobi, H Richter, J Lademann, H Schaefer, U Blume-Peytavi.   

Abstract

The transfollicular administration of pharmacologically active molecules is of current therapeutic interest, mainly with regard to delivery to specific sites of the hair follicle (HF) and the reduction of hepatic metabolism and systemic toxicity. HF are privileged pathways for specific molecules depending on formulations, which enter faster into these shunts than through the stratum corneum. The aim was to optimize the delivery of fluorescent microspheres into the HF, thereby, developing a standardized protocol for follicular targeting with microspheres. The number of HF showing penetration, as well as the depth of penetration, was determined. Freshly excised skin samples with terminal HF were divided into groups, with or without prior treatment with cyanoacrylate skin surface stripping-technique (CSSS). Thereafter microspheres at a size of 0.75-6.0 microm were applied according to the developed standardized protocol. Skin biopsies were obtained, shock-frozen, and sectioned in 5 microm slices. We demonstrated a selective penetration route of the microspheres into the HF. Optimal microsphere size proved to be approximately 1.5 microm, with a 55% rate of all HF, and with a maximum penetration depth of >2300 microm. Without previous CSSS treatment of the skin, the transfollicular microsphere penetration was below 27% with a maximum penetration depth of 1000 microm. Thus, the basis for follicular targeting of essential structures containing stem cells for keratinocytes, melanocytes, and mast cells has been laid.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191557     DOI: 10.1111/j.0022-202X.2004.22717.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  43 in total

1.  Transcutaneous DNA immunization following waxing-based hair depilation elicits both humoral and cellular immune responses.

Authors:  Gang Xiao; Xinran Li; Amit Kumar; Zhengrong Cui
Journal:  Eur J Pharm Biopharm       Date:  2012-07-03       Impact factor: 5.571

Review 2.  In vivo methods for the assessment of topical drug bioavailability.

Authors:  Christophe Herkenne; Ingo Alberti; Aarti Naik; Yogeshvar N Kalia; François-Xavier Mathy; Véronique Préat; Richard H Guy
Journal:  Pharm Res       Date:  2007-11-06       Impact factor: 4.200

Review 3.  [How safe are nanoparticles?].

Authors:  J Lademann; M Meinke; W Sterry; A Patzelt
Journal:  Hautarzt       Date:  2009-04       Impact factor: 0.751

Review 4.  Understanding engineered nanomaterial skin interactions and the modulatory effects of ultraviolet radiation skin exposure.

Authors:  Samreen Jatana; Lisa A DeLouise
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-03

Review 5.  [Environmental pollution and skin aging].

Authors:  A Vierkötter
Journal:  Hautarzt       Date:  2011-08       Impact factor: 0.751

6.  Hair follicle: a novel source of multipotent stem cells for tissue engineering and regenerative medicine.

Authors:  Panagiotis Mistriotis; Stelios T Andreadis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-03       Impact factor: 6.389

Review 7.  Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.

Authors:  Sharifa Al-Zahrani; Marija Zaric; Cian McCrudden; Chris Scott; Adrien Kissenpfennig; Ryan F Donnelly
Journal:  Expert Opin Drug Deliv       Date:  2012-04-05       Impact factor: 6.648

8.  Nanoparticles and their interactions with the dermal barrier.

Authors:  Marc Schneider; Frank Stracke; Steffi Hansen; Ulrich F Schaefer
Journal:  Dermatoendocrinol       Date:  2009-07

Review 9.  Convergence of nanotechnology and cancer prevention: are we there yet?

Authors:  David G Menter; Sherri L Patterson; Craig D Logsdon; Scott Kopetz; Anil K Sood; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-24

Review 10.  Single compartment drug delivery.

Authors:  Michael J Cima; Heejin Lee; Karen Daniel; Laura M Tanenbaum; Aikaterini Mantzavinou; Kevin C Spencer; Qunya Ong; Jay C Sy; John Santini; Carl M Schoellhammer; Daniel Blankschtein; Robert S Langer
Journal:  J Control Release       Date:  2014-05-04       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.